PMID- 18183025 OWN - NLM STAT- MEDLINE DCOM- 20080221 LR - 20220318 IS - 1546-1696 (Electronic) IS - 1087-0156 (Linking) VI - 26 IP - 1 DP - 2008 Jan TI - A quantitative analysis of kinase inhibitor selectivity. PG - 127-32 LID - 10.1038/nbt1358 [doi] AB - Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome. We present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome. The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns. To enable a global analysis of the results, we introduce the concept of a selectivity score as a general tool to quantify and differentiate the observed interaction patterns. We further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity. FAU - Karaman, Mazen W AU - Karaman MW AD - Ambit Biosciences, 4215 Sorrento Valley Blvd., San Diego, California 92121, USA. FAU - Herrgard, Sanna AU - Herrgard S FAU - Treiber, Daniel K AU - Treiber DK FAU - Gallant, Paul AU - Gallant P FAU - Atteridge, Corey E AU - Atteridge CE FAU - Campbell, Brian T AU - Campbell BT FAU - Chan, Katrina W AU - Chan KW FAU - Ciceri, Pietro AU - Ciceri P FAU - Davis, Mindy I AU - Davis MI FAU - Edeen, Philip T AU - Edeen PT FAU - Faraoni, Raffaella AU - Faraoni R FAU - Floyd, Mark AU - Floyd M FAU - Hunt, Jeremy P AU - Hunt JP FAU - Lockhart, Daniel J AU - Lockhart DJ FAU - Milanov, Zdravko V AU - Milanov ZV FAU - Morrison, Michael J AU - Morrison MJ FAU - Pallares, Gabriel AU - Pallares G FAU - Patel, Hitesh K AU - Patel HK FAU - Pritchard, Stephanie AU - Pritchard S FAU - Wodicka, Lisa M AU - Wodicka LM FAU - Zarrinkar, Patrick P AU - Zarrinkar PP LA - eng PT - Journal Article PL - United States TA - Nat Biotechnol JT - Nature biotechnology JID - 9604648 RN - 0 (Protein Kinase Inhibitors) RN - 0 (Proteome) RN - EC 2.7.- (Phosphotransferases) SB - IM MH - Binding Sites MH - Enzyme Activation MH - Humans MH - Phosphotransferases/*antagonists & inhibitors MH - Protein Binding MH - Protein Interaction Mapping/*methods MH - Protein Kinase Inhibitors/*chemistry MH - Proteome/*chemistry MH - *Quantitative Structure-Activity Relationship EDAT- 2008/01/10 09:00 MHDA- 2008/02/22 09:00 CRDT- 2008/01/10 09:00 PHST- 2007/07/19 00:00 [received] PHST- 2007/11/08 00:00 [accepted] PHST- 2008/01/10 09:00 [pubmed] PHST- 2008/02/22 09:00 [medline] PHST- 2008/01/10 09:00 [entrez] AID - nbt1358 [pii] AID - 10.1038/nbt1358 [doi] PST - ppublish SO - Nat Biotechnol. 2008 Jan;26(1):127-32. doi: 10.1038/nbt1358.